Expression of ASAP1 and FAK in gastric cancer and its clinicopathological significance

Luo,Qiong; Zhang,Suyun; Zhang,Donghuan; Yuan,Fang; Chen,Xiangqi; Yang,Sheng

doi:10.3892/ol.2020.11612

Expression of ASAP1 and FAK in gastric cancer and its clinicopathological significance

Authors:
- Qiong Luo
- Suyun Zhang
- Donghuan Zhang
- Fang Yuan
- Xiangqi Chen
- Sheng Yang
View Affiliations

Affiliations: Department of Oncology Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China, Department of Respiratory Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China
Published online on: May 13, 2020 https://doi.org/10.3892/ol.2020.11612
Pages: 974-980

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to analyze the expression levels of adenosine diphosphate ribosylation factor guanylate kinase 1 (ASAP1) and focal adhesion kinase (FAK) in gastric cancer (GC) tissues in order to explore their association with clinicopathological features and prognosis. A total of 32 patients with GC were enrolled in the present study. All patients had complete clinical follow‑up data and paraffin‑embedded normal gastric mucosal tissues. The expression levels of ASAP1 and FAK in these tissues were measured by immunohistochemistry. The associations of ASAP1 and FAK expression with clinicopathological factors and the survival of patients with GC were subsequently analyzed. The expression levels of ASAP1 (59.4%) and FAK (68.8%) in GC tissues were significantly higher than those in normal gastric mucosal tissues (28.1 and 40.6%, P<0.05). The expression levels of ASAP1 and FAK were associated with depth of invasion, lymph node metastasis and pathological stage (P<0.05). ASAP1 expression was positively associated with FAK expression (P<0.001). In addition, ASAP1 and FAK expression levels were negatively associated with disease‑free survival time and overall survival time (P<0.05). The 5‑year overall survival rate was significantly higher in patients with negative ASAP1 or FAK expression compared with that in patients with positive ASAP1 or FAK expression (P<0.05). In conclusion, ASAP1 and FAK were highly expressed in human GC tissues and may serve a synergistic role in promoting tumorigenesis, progression, invasion and metastasis in patients with GC. ASAP1 and FAK expression in GC were associated with patient's survival. Therefore, ASAP1 and FAK may represent novel molecular markers for the pathophysiology and prognosis of GC.

View Figures

View References

1	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
2	Li J, Meng Q, Sun Y and Qing H: Inhibition of focal adhesion kinase induces apoptosis in human gastric carcinoma cells (SGC-7901). Mol Biol Rep. 40:401–406. 2013. View Article : Google Scholar : PubMed/NCBI
3	Li Z, Lei H, Luo M, Wang Y, Dong L, Ma Y, Liu C, Song W, Wang F, Zhang J, et al: DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer. 18:43–54. 2015. View Article : Google Scholar : PubMed/NCBI
4	Kanda M and Kodera Y: Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol. 21:98382015. View Article : Google Scholar : PubMed/NCBI
5	Hou T, Yang C, Tong C, Zhang H, Xiao J and Li J: Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer. Int J Clin Exp Pathol. 7:2802014.PubMed/NCBI
6	Zhang L, Shi SB, Zhu Y, Qian TT and Wang HL: Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 22:142–149. 2018.PubMed/NCBI
7	Randazzo PA, Inoue H and Bharti S: Arf GAPs as regulators of the actin cytoskeleton. Biol Cell. 99:583–600. 2007. View Article : Google Scholar : PubMed/NCBI
8	Zhang T, Zhao G, Yang C, Dong P, Watari H, Zeng L, Pfeffer LM and Yue J: Lentiviral vector mediated-ASAP1 expression promotes epithelial to mesenchymal transition in ovarian cancer cells. Oncol Lett. 15:4432–4438. 2018.PubMed/NCBI
9	Yang L, Xue Y, Liu J, Zhuang J, Shen L, Shen B, Yan J and Guo H: Long noncoding RNA ASAP1-IT1 promotes cancer stemness and predicts a poor prognosis in patients with bladder cancer. Neoplasma. 64:847–855. 2017. View Article : Google Scholar : PubMed/NCBI
10	Sulzmaier FJ, Jean C and Schlaepfer DD: FAK in cancer: Mechanistic findings and clinical applications. Nat Rev Cancer. 14:5982014. View Article : Google Scholar : PubMed/NCBI
11	Fan H, Zhao X, Sun S, Luo M and Guan JL: Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo. J Biol Chem. 288:3322–3333. 2013. View Article : Google Scholar : PubMed/NCBI
12	Fu W, Hall JE and Schaller MD: Focal adhesion kinase-regulated signaling events in human cancer. Biomol Concepts. 3:225–240. 2012. View Article : Google Scholar : PubMed/NCBI
13	Thanapprapasr D, Previs RA, Hu W, Ivan C, Armaiz-Pena GN, Dorniak PL, Hansen JM, Rupaimoole R, Huang J, Dalton HJ, et al: PTEN expression as a predictor of response to focal adhesion kinase inhibition in uterine cancer. Mol Cancer Ther. 14:1466–1475. 2015. View Article : Google Scholar : PubMed/NCBI
14	Zeng XQ, Li N, Ma LL, Tseng YJ, Zhao NQ and Chen SY: Prognostic value of focal adhesion kinase (FAK) in human solid carcinomas: A meta-analysis. PLoS One. 11:e01626662016. View Article : Google Scholar : PubMed/NCBI
15	Sobin L: International Union Against Cancer (UICC) TNM classification of malignant tumours. Oesophagus including Oesophagogastric Junction. 66–72. 2009.
16	Buqué A, Bloy N, Aranda F, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Marabelle A, et al: Trial watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology. 4:e10088142015. View Article : Google Scholar : PubMed/NCBI
17	Petrelli NJ, Winer EP, Brahmer J, Dubey S, Smith S, Thomas C, Vahdat LT, Obel J, Vogelzang N, Markman M, et al: Clinical Cancer Advances 2009: Major research advances in cancer treatment, prevention, and screening-a report from the American Society of Clinical Oncology. J Clin Oncol. 27:6052–6069. 2009. View Article : Google Scholar : PubMed/NCBI
18	Yazici O, Sendur MA, Ozdemir N and Aksoy S: Targeted therapies in gastric cancer and future perspectives. World J Gastroenterol. 22:471–489. 2016. View Article : Google Scholar : PubMed/NCBI
19	Feng R, Zhang X and Yang S: Research status quo and progression in targeted therapy for advanced gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 19:1191–1196. 2016.(In Chinese). PubMed/NCBI
20	Müller T, Stein U, Poletti A, Garzia L, Rothley M, Plaumann D, Thiele W, Bauer M, Galasso A, Schlag P, et al: ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients. Oncogene. 29:2393–2403. 2010. View Article : Google Scholar : PubMed/NCBI
21	Randazzo PA, Andrade J, Miura K, Brown MT, Long YQ, Stauffer S, Roller P and Cooper JA: The Arf GTPase-activating protein ASAP1 regulates the actin cytoskeleton. Proc Natl Acad Sci USA. 97:4011–4016. 2000. View Article : Google Scholar : PubMed/NCBI
22	Liu Y, Yerushalmi GM, Grigera PR and Parsons JT: Mislocalization or reduced expression of Arf GTPase-activating protein ASAP1 inhibits cell spreading and migration by influencing Arf1 GTPase cycling. J Biol Chem. 280:8884–8892. 2005. View Article : Google Scholar : PubMed/NCBI
23	Inoue H and Randazzo PA: Arf GAPs and their interacting proteins. Traffic. 8:1465–1475. 2007. View Article : Google Scholar : PubMed/NCBI
24	Nie Z and Randazzo PA: Arf GAPs and membrane traffic. J Cell Sci. 119:1203–1211. 2006. View Article : Google Scholar : PubMed/NCBI
25	Brown MT, Andrade J, Radhakrishna H, Donaldson JG, Cooper JA and Randazzo PA: ASAP1, a phospholipid-dependent arf GTPase-activating protein that associates with and is phosphorylated by Src. Mol Cell Biol. 18:7038–7051. 1998. View Article : Google Scholar : PubMed/NCBI
26	Kowanetz K, Husnjak K, Höller D, Kowanetz M, Soubeyran P, Hirsch D, Schmidt MHH, Pavelic K, De Camilli P, Randazzo PA and Dikic I: CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors. Mol Biol Cell. 15:3155–3166. 2004. View Article : Google Scholar : PubMed/NCBI
27	Oda A, Wada I, Miura K, Okawa K, Kadoya T, Kato T, Nishihara H, Maeda M, Tanaka S, Nagashima K, et al: CrkL directs ASAP1 to peripheral focal adhesions. J Biol Chem. 278:6456–6460. 2003. View Article : Google Scholar : PubMed/NCBI
28	Liu Y, Loijens JC, Martin KH, Karginov AV and Parsons JT: The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. Mol Biol Cell. 13:2147–2156. 2002. View Article : Google Scholar : PubMed/NCBI
29	Schaller MD, Hildebrand JD and Parsons JT: Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases. Mol Biol Cell. 10:3489–3505. 1999. View Article : Google Scholar : PubMed/NCBI
30	Weiner TM, Craven RJ, Craven RJ and Cance WG: Expression of focal adhesion kinase gene and invasive cancer. Lancet. 342:1024–1025. 1993. View Article : Google Scholar : PubMed/NCBI
31	Miyazaki T, Kato H, Nakajima M, Sohda M, Fukai Y, Masuda N, Manda R, Fukuchi M, Tsukada K and Kuwano H: FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer. 89:1402003. View Article : Google Scholar : PubMed/NCBI
32	Park JH, Lee BL, Yoon J, Kim J, Kim MA, Yang HK and Kim WH: Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer. Hum Pathol. 41:1664–1673. 2010. View Article : Google Scholar : PubMed/NCBI
33	Lai HC, Zhuang LF, Liu X, Wieland M and Zhang ZY and Zhang ZY: The influence of surface energy on early adherent events of osteoblast on titanium substrates. J Biomed Mater Res A. 93:289–296. 2010.PubMed/NCBI
34	Wang J, Wen T, Li Z, Che X, Gong L, Yang X, Zhang J, Tang H, He L, Qu X and Liu Y: MicroRNA-1224 inhibits tumor metastasis in intestinal-type gastric cancer by directly targeting FAK. Front Oncol. 9:2222019. View Article : Google Scholar : PubMed/NCBI
35	Yoon HY, Jacques K, Nealon B, Stauffer S, Premont RT and Randazzo P: Differences between AGAP1, ASAP1 and Arf GAP1 in substrate recognition: Interaction with the N-terminus of Arf1. Cell Signal. 16:1033–1044. 2004. View Article : Google Scholar : PubMed/NCBI
36	Vitali T, Girald-Berlingeri S, Randazzo PA and Chen PW: Arf GAPs: A family of proteins with disparate functions that converge on a common structure, the integrin adhesion complex. Small GTPases. 10:280–288. 2019.PubMed/NCBI
37	Brami-Cherrier K, Gervasi N, Arsenieva D, Walkiewicz K, Boutterin MC, Ortega A, Leonard PG, Seantier B, Gasmi L, Bouceba T, et al: FAK dimerization controls its kinase-dependent functions at focal adhesions. EMBO J. 33:356–370. 2014. View Article : Google Scholar : PubMed/NCBI